MedCity News

APRIL 26, 2024

million price tag, the same as a CSL Behring gene therapy already available for treating the inherited bleeding disorder. The FDA has approved Beqvez, a Pfizer gene therapy developed for moderate-to-severe hemophilia B. The one-time treatment carries a $3.5

FDA 107

FDA Biopharma Pharma 107

MedCity News

JULY 1, 2022

The $100 million price tag is in the neighborhood of the going rate for these vouchers, which grant a company a shorter regulatory review timeline for a drug that addresses a rare or neglected disease. Novartis is acquiring an FDA priority review voucher from Mallinckrodt Pharmaceuticals.

FDA 107

FDA Pharmaceutical Biopharma Pharma 107

PM360

NOVEMBER 12, 2023

This can help improve biopharma brands’ marketing approach as they can use this privacy-safe data and reach out to HCPs with support materials and timely information when they are more receptive.

Marketing 59

Marketing Media Patients Healthcare 59

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52